CD8A and neoplasm: In the context of colon cancer, high CXCL11 expression is linked to increased levels of anti-tumor immune cells and particularly activated CD8+ T cells and natural killer cells while decreasing the proportion of tumor-promoting immune cells, suggesting a favorable role of CXCL11 in the anti-tumor immune response [49].